Investigation of the effect of β-lactam antibiotics and serum on growth and gene expression in Escherichia coli strain JJ1886
Investigation of the effect of β-lactam antibiotics and serum on growth and gene expression in Escherichia coli strain JJ1886
Background/aim: β-Lactamase-producing Escherichia coli strain JJ1886 is an epidemic clone with high virulence properties. Becausethis strain can survive in the bloodstream, we aimed here to understand how β-lactam antibiotics and human serum affect the growthand gene expression of this bacterium.Materials and methods: We report the time-dependent growth effect of normal human serum and heat-inactivated serum, togetherwith β-lactam antibiotics (including cefotaxime, ceftazidime, and carbenicillin), for E. coli strain JJ1886. Relative gene expression ofβ-lactamase-related genes (encoding the β-lactamase regulator, CTX-M-15, and peptidoglycan glycosyltransferase) and serum survivalassociated genes (encoding lipoprotein NlpI, murein lipoprotein, lipopolysaccharide core heptose (I) kinase, lipopolysaccharidebiosynthesis protein, capsule synthesis protein, and phosphate transport system) were investigated by RT-qPCR.Results: Cells proliferated during the exponential growth phase when the bacterium was treated with human serum. However,cefotaxime and ceftazidime together with serum had a bactericidal effect at each of the tested time points. Downregulation was observedin gene-encoding lipoprotein NlpI as a result of treatment with carbenicillin.Conclusion: Serum plus cefotaxime or ceftazidime had bactericidal activities. When the bacterium was treated with human serum andβ-lactam antibiotics, there were no significant changes in relative gene expression, except for the nlpI gene.
___
- Qin W, Panunzio M, Biondi S. Beta-lactam antibiotics
renaissance. Antibiotics (Basel) 2014; 3: 193-215.
- Bozcal E, Dagdeviren M. Toxicity of β-lactam antibiotics:
pathophysiology, molecular biology and possible recovery
strategies. In: Malangu N, editor. Poisoning: From Specific
Toxic Agents to Novel Rapid and Simplified Techniques for
Analysis. Rijeka, Croatia: InTech Open; 2017. pp. 87-105.
- Worthington RJ, Melander C. Overcoming resistance to betalactam antibiotics. J Org Chem 2013; 78: 4207-4213.
- Li L, Wang Q, Zhang H, Yang M, Khan MI, Zhou X. Sensor
histidine kinase is a beta-lactam receptor and induces
resistance to beta-lactam antibiotics. P Natl Acad Sci USA
2016; 113: 1648-1653.
- D’Andrea MM, Arena F, Pallecchi L, Rossolini GM. CTX-Mtype beta-lactamases: a successful story of antibiotic resistance.
Int J Med Microbiol 2013; 303: 305-317.
- Zhao WH, Hu ZQ. Epidemiology and genetics of CTX-M
extended-spectrum beta-lactamases in Gram-negative
bacteria. Crit Rev Microbiol 2013; 39: 79-101.
- Shakil S, Khan AU. Detection of CTX-M-15-producing and
carbapenem-resistant Acinetobacter baumannii strains from
urine from an Indian hospital. J Chemother 2010; 22: 324-327.
- Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25bST131: a pandemic, multiresistant, community-associated
strain. J Antimicrob Chemoth 2011; 66: 1-14.
- Coelho A, Gonzalez-Lopez JJ, Miro E, Alonso-Tarres C, Mirelis
B, Larrosa MN, Bartolome RM, Andreu A, Navarro F, Johnson
JR et al. Characterisation of the CTX-M-15-encoding gene in
Klebsiella pneumoniae strains from the Barcelona metropolitan
area: plasmid diversity and chromosomal integration. Int J
Antimicrob Agents 2010; 36: 73-78.
- Fischer J, Rodríguez I, Baumann B, Guiral E, Beutin L,
Schroeter A, Kaesbohrer A, Pfeifer Y, Helmuth R, Guerra B.
blaCTX-M-15-carrying Escherichia coli and Salmonella isolates
from livestock and food in Germany. J Antimicrob Chemoth
2014; 69: 2951-2958.
- Kjeldsen TSB, Overgaard M, Nielsen SS, Bortolaia V, Jelsbak L,
Sommer M, Guardabassi L, Olsen JE. CTX-M-1 β-lactamase
expression in Escherichia coli is dependent on cefotaxime
concentration, growth phase and gene location. J Antimicrob
Chemoth 2015; 70: 62-70.
- Sabra AH, Araj GF, Kattar MM, Abi-Rached RY, Khairallah
MT, Klena JD, Matar GM. Molecular characterization of ESBLproducing Shigella sonnei isolates from patients with bacilliary
dysentery in Lebanon. J Infect Dev Ctries 2009; 3: 300-305.
- Lindquist S, Galleni M, Lindberg F, Normark S. Signalling
proteins in enterobacterial AmpC beta-lactamase regulation.
Mol Microbiol 1989; 3: 1091-1102.
- Banerjee R, Johnson JR. Escherichia coli ST131: variations on
a theme of clonal expansion. Enferm Infec Micr Cl 2013; 31:
355-356.
- Dahbi G, Mora A, Lopez C, Alonso MP, Mamani R, Marzoa J,
Coira A, Garcia-Garrote F, Pita JM, Velasco D et al. Emergence
of new variants of ST131 clonal group among extraintestinal
pathogenic Escherichia coli producing extended-spectrum
beta-lactamases. Int J Antimicrob Agents 2013; 42: 347-351.
- Andersen PS, Stegger M, Aziz M, Contente-Cuomo T, Gibbons
HS, Keim P, Sokurenko EV, Johnson JR, Price LB. Complete
genome sequence of the epidemic and highly virulent CTXM-15-producing H30-Rx subclone of Escherichia coli ST131.
Genome Announcements 2013; 1: 1-2.
- Shaik S, Ranjan A, Tiwari SK, Hussain A, Nandanwar N,
Kumar N, Jadhav S, Semmler T, Baddam R, Islam MA et al.
Comparative genomic analysis of globally dominant ST131
clone with other epidemiologically successful extraintestinal
pathogenic Escherichia coli (ExPEC) Lineages. mBio 2017; 8:
1-15.
- Johnson JR, Porter S, Thuras P, Castanheira M. The pandemic
H30 subclone of sequence type 131 (ST131) as the leading
cause of multidrug-resistant Escherichia coli infections in the
United States (2011–2012). Open Forum Infect Dis 2017; 4:
ofx089.
- Shin J, Ko KS. Effect of plasmids harbouring blaCTX-M on the
virulence and fitness of Escherichia coli ST131 isolates. Int J
Antimicrob Agents 2015; 46: 214-218.
- Owens RC Jr, Johnson JR, Stogsdill P, Yarmus L, Lolans K,
Quinn J. Community transmission in the United States of a
CTX-M-15-producing sequence type ST131 Escherichia coli
strain resulting in death. J Clin Microbiol 2011; 49: 3406-3408.
- Phan MD, Peters KM, Sarkar S, Lukowski SW, Allsopp LP,
Gomes Moriel D, Achard ME, Totsika M, Marshall VM,
Upton M et al. The serum resistome of a globally disseminated
multidrug resistant uropathogenic Escherichia coli clone. PLoS
Genet 2013; 9: e1003834.
- Weiser JN, Gotschlich EC. Outer membrane protein A
(OmpA) contributes to serum resistance and pathogenicity of
Escherichia coli K-1. Infect Immun 1991; 59: 2252-2258.
- Miajlovic H, Smith SG. Bacterial self-defence: how Escherichia
coli evades serum killing. FEMS Microbiol Lett 2014; 354: 1-9.
- Tseng YT, Wang SW, Kim KS, Wang YH, Yao YF, Chen CC,
Chiang CW, Hsieh PC, Teng CH. NlpI facilitates deposition
of C4bp on Escherichia coli by blocking classical complementmediated killing, which results in high-level bacteremia. Infect
Immun 2012; 80: 3669-3678.
- Diao J, Bouwman C, Yan D, Kang J, Katakam AK, Liu P, Pantua
H, Abbas AR, Nickerson NN, Austin C et al. Peptidoglycan
association of murein lipoprotein is required for KpsDdependent group 2 capsular polysaccharide expression and
serum resistance in a uropathogenic Escherichia coli isolate.
mBio 2017; 8: 1-15.
- Lamarche MG, Dozois CM, Daigle F, Caza M, Curtiss R 3rd,
Dubreuil JD, Harel J. Inactivation of the pst system reduces the
virulence of an avian pathogenic Escherichia coli O78 strain.
Infect Immun 2005; 73: 4138-4145.
- Liu YF, Yan JJ, Lei HY, Teng CH, Wang MC, Tseng CC, Wu JJ.
Loss of outer membrane protein C in Escherichia coli contributes
to both antibiotic resistance and escaping antibody-dependent
bactericidal activity. Infect Immun 2012; 80: 1815-1822.
- Putrins M, Kogermann K, Lukk E, Lippus M, Varik V, Tenson
T. Phenotypic heterogeneity enables uropathogenic Escherichia
coli to evade killing by antibiotics and serum complement.
Infect Immun 2015; 83: 1056-1067.
- Andrews JM. Determination of minimum inhibitory
concentrations. J Antimicrob Chemother 2001; 48 (Suppl. 1):
5-16.
- European Committee for Antimicrobial Susceptibility Testing
of the European Society of Clinical Microbiology and Infectious
Diseases. EUCAST Definitive Document E.DEF 3.1, June 2000:
Determination of minimum inhibitory concentrations (MICs)
of antibacterial agents by agar dilution. Clin Microbiol Infect
2000; 6: 509-515.
- Cremet L, Broquet A, Jacqueline C, Chaillou C, Asehnoune K,
Corvec S, Caroff N. Innate immune evasion of Escherichia coli
clinical strains from orthopedic implant infections. Eur J Clin
Microbiol Infect Dis 2016; 35: 993-999.
- Miles AA, Misra SS, Irwin JO. The estimation of the bactericidal
power of the blood. J Hyg (Lond) 1938; 38: 732-749.
- Wang CY, Wang SW, Huang WC, Kim KS, Chang NS, Wang
YH, Wu MH, Teng CH. Prc contributes to Escherichia coli
evasion of classical complement-mediated serum killing. Infect
Immun 2012; 80: 3399-3409.
- Forde BM, Ben Zakour NL, Stanton-Cook M, Phan MD,
Totsika M, Peters KM, Chan KG, Schembri MA, Upton M,
Beatson SA. The complete genome sequence of Escherichia
coli EC958: a high quality reference sequence for the globally
disseminated multidrug resistant E. coli O25b:H4-ST131 clone.
PLoS One 2014; 9: e104400.
- Keepers TR, Gomez M, Celeri C, Nichols WW, Krause KM.
Bactericidal activity, absence of serum effect, and time-kill
kinetics of ceftazidime–avibactam against beta-lactamaseproducing Enterobacteriaceae and Pseudomonas aeruginosa.
Antimicrob Agents Chemother 2014; 58: 5297-5305.
- Brauner A, Fridman O, Gefen O, Balaban NQ. Distinguishing
between resistance, tolerance and persistence to antibiotic
treatment. Nat Rev Microbiol 2016; 14: 320-330.
- Burgess DS, Hall RG. In vitro killing of parenteral beta-lactams
against standard and high inocula of extended-spectrum betalactamase and non-ESBL producing Klebsiella pneumoniae.
Diagn Microbiol Infect Dis 2004; 49: 41-46.
- Dutcher BS, Reynard AM, Beck ME, Cunningham RK.
Potentiation of antibiotic bactericidal activity by normal
human serum. Antimicrob Agents Chemother 1978; 13: 820-
826.
- Singh SK, Parveen S, SaiSree L, Reddy M. Regulated proteolysis
of a cross-link-specific peptidoglycan hydrolase contributes
to bacterial morphogenesis. P Natl Acad Sci USA 2015; 112:
10956-10961.
- Neu HC, Swarz H. Resistance of Escherichia coli and Salmonella
typhimurium to carbenicillin. J Gen Microbiol 1969; 58: 301-
305.
- Lee S, Bae S. Molecular viability testing of viable but nonculturable bacteria induced by antibiotic exposure. Microb
Biotechnol (in press).
- Pagani L, Dell’Amico E, Migliavacca R, D’Andrea MM,
Giacobone E, Amicosante G, Romero E, Rossolini GM.
Multiple CTX-M-type extended-spectrum beta-lactamases in
nosocomial isolates of Enterobacteriaceae from a hospital in
northern Italy. J Clin Microbiol 2003; 41: 4264-4269.